Zobrazeno 1 - 10 of 44 pro vyhledávání: '"Sandhya S Nair"'
4
Akademický článek
Real-world treatment patterns and outcomes in relapsed/refractory multiple myeloma (1-3 prior lines): Flatiron database.
Autor: Dhakal B; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI., Einsele H; Department of Internal Medicine II, Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Schecter JM; Janssen Research & Development, Raritan, NJ., Deraedt W; Janssen Pharmaceutica NV, Beerse, Belgium., Lendvai N; Janssen Research & Development, Raritan, NJ., Slaughter A; Cilag GmbH International, Zug, Switzerland., Lonardi C; Janssen, Buenos Aires, Argentina., Nair S; Janssen Pharmaceutica NV, Beerse, Belgium., He J; Janssen Global Services, LLC, Raritan, NJ., Kharat A; Janssen Scientific Affairs, LLC, Horsham, PA., Cost P; Janssen Global Services, LLC, Raritan, NJ., Valluri S; Janssen Global Services, LLC, Raritan, NJ., Yong K; Department of Haematology, Cancer Institute, University College London Cancer Institute, London, United Kingdom.
Publikováno v: Blood advances [Blood Adv] 2024 Oct 08; Vol. 8 (19), pp. 5062-5071.
Zobrazit plný text záznamu
5
Akademický článek
Talquetamab Versus Real-World Physician's Choice Treatment: Comparative Effectiveness in Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma.
Autor: Ye JC; MD Anderson Cancer Center, University of Texas, Houston, TX. Electronic address: JCYe@mdanderson.org., Biran N; Hackensack University Medical Center, Hackensack, NJ., Nair S; Janssen Pharmaceutica NV, Beerse, Belgium., Lin X; Janssen Global Services, Horsham, PA., Qi K; Janssen Research & Development, Titusville, NJ., Londhe A; Janssen Research & Development, Titusville, NJ., Ammann E; Janssen Global Services, Raritan, NJ., Renaud T; Janssen Research & Development, Raritan, NJ., Kane C; Janssen Research & Development, Spring House, PA., Parekh T; Janssen Research & Development, Bridgewater, NJ., Gray K; Janssen Research & Development, Spring House, PA., Peterson S; Janssen Research & Development, Horsham, PA., Costa LJ; University of Alabama at Birmingham, Birmingham, AL.
Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Aug 13. Date of Electronic Publication: 2024 Aug 13.
Zobrazit plný text záznamu
6
Akademický článek
Results of comprehensive genetic testing in patients presenting to a multidisciplinary inherited heart disease clinic in India.
Autor: Chockalingam P; Centre for Inherited Heart Disease, Department of Cardiology, Kauvery Hospital, Chennai, India. Electronic address: priyachockalingam@cardiacwellnessinstitute.com., Geetha TS; Principal Scientist, Operations, Medgenome Labs, Bengaluru, India., Nair S; Senior Manager, Operations, Medgenome Labs, Bengaluru, India., Rajakumar N; Senior Genetic Counselor, Neuberg Centre for Genomic Medicine, Chennai, India., Raja DC; Cardiac Electrophysiologist, Department of Cardiology, Kauvery Hospital, Chennai, India., Lokhandwala Y; Cardiac Electrophysiologist, Holy Family Hospital, Mumbai, India., Chaturvedi V; Senior Consultant & Professor of Cardiology, Amrita Institute of Medical Science and Research, Faridabad, India., Selvaraj RJ; Professor of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India., Ramasamy S; Cardiac Electrophysiologist, Dr. Kamakshi Memorial Hospitals, Chennai, India., Sharda S; Director, Genomics Development and Implementation, Neuberg Centre for Genomic Medicine, Ahmedabad, India., Sundar C; Interventional Cardiologist, Department of Cardiology, Kauvery Hospital, Chennai, India., Anantharaman R; Centre for Inherited Heart Disease, Department of Cardiology, Kauvery Hospital, Chennai, India; Interventional Cardiologist, Department of Cardiology, Kauvery Hospital, Chennai, India.
Publikováno v: Indian heart journal [Indian Heart J] 2024 Jul-Aug; Vol. 76 (4), pp. 260-267. Date of Electronic Publication: 2024 Jul 14.
Zobrazit plný text záznamu
7
Akademický článek
The Genetic Drivers of Juvenile, Young, and Early-Onset Parkinson's Disease in India.
Autor: Andrews SV; Denali Therapeutics, South San Francisco, California, USA., Kukkle PL; Manipal Hospital, Bangalore, India.; Parkinson's Disease and Movement Disorders Clinic, Bangalore, India., Menon R; MedGenome Labs Ltd, Bangalore, India., Geetha TS; MedGenome Labs Ltd, Bangalore, India., Goyal V; All India Institute of Medical Sciences (AIIMS), New Delhi, India.; Medanta Hospital, New Delhi, India.; Medanta, The Medicity, Gurgaon, India., Kandadai RM; Nizams Institute of Medical Sciences (NIMS), Hyderabad, India.; Citi Neuro Centre, Hyderabad, India., Kumar H; Institute of Neurosciences Kolkata, Kolkata, India., Borgohain R; Nizams Institute of Medical Sciences (NIMS), Hyderabad, India.; Citi Neuro Centre, Hyderabad, India., Mukherjee A; Bangur Institute of Neurosciences and Institute of Post Graduate Medical Education and Research (IPGME&R), Kolkata, India., Wadia PM; Jaslok Hospital and Research Centre, Mumbai, India., Yadav R; National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India., Desai S; Department of Neurology, Shree Krishna Hospital and Pramukhaswami Medical College, Bhaikaka University, Anand, India., Kumar N; All India Institute of Medical Sciences, Rishikesh, India.; All India Institute of Medical Sciences, Bibinagar (Hyderabad Metropolitan Region), Bibinagar, India., Joshi D; Department of Neurology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India., Murugan S; MedGenome Labs Ltd, Bangalore, India., Biswas A; Bangur Institute of Neurosciences and Institute of Post Graduate Medical Education and Research (IPGME&R), Kolkata, India., Pal PK; National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India., Oliver M; MedGenome Labs Ltd, Bangalore, India., Nair S; MedGenome Labs Ltd, Bangalore, India., Kayalvizhi A; MedGenome Labs Ltd, Bangalore, India., Samson PL; MedGenome Labs Ltd, Bangalore, India., Deshmukh M; MedGenome Labs Ltd, Bangalore, India., Bassi A; MedGenome Labs Ltd, Bangalore, India., Sandeep C; MedGenome Labs Ltd, Bangalore, India., Mandloi N; MedGenome Labs Ltd, Bangalore, India., Davis OB; Denali Therapeutics, South San Francisco, California, USA., Roberts MA; Denali Therapeutics, South San Francisco, California, USA., Leto DE; Denali Therapeutics, South San Francisco, California, USA., Henry AG; Denali Therapeutics, South San Francisco, California, USA., Di Paolo G; Denali Therapeutics, South San Francisco, California, USA., Muthane U; Parkinson and Ageing Research Foundation, Bangalore, India., Das SK; Bangur Institute of Neurosciences and Institute of Post Graduate Medical Education and Research (IPGME&R), Kolkata, India., Peterson AS; MedGenome Labs Ltd, Bangalore, India., Sandmann T; Denali Therapeutics, South San Francisco, California, USA., Gupta R; MedGenome Labs Ltd, Bangalore, India., Ramprasad VL; MedGenome Labs Ltd, Bangalore, India.
Publikováno v: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2024 Feb; Vol. 39 (2), pp. 339-349. Date of Electronic Publication: 2023 Nov 28.
Zobrazit plný text záznamu
8
Akademický článek
A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients.
Autor: Freedland SJ; Cedars-Sinai Medical Center, Los Angeles, CA, USA. Stephen.Freedland@cshs.org.; Durham VA Medical Center, Durham, NC, USA. Stephen.Freedland@cshs.org., Nair S; Janssen Pharmaceutica NV, Beerse, Belgium., Lin X; Janssen Global Services, Horsham, PA, USA., Karsh L; The Urology Center of Colorado, Denver, CO, USA., Pieczonka C; Associated Medical Professionals of NY, Syracuse, NY, USA., Potluri R; Putnam Associates, HEOR & RWE, New York, NY, USA., Brookman-May SD; Janssen Research & Development, Spring House, PA, USA.; Department of Urology, Ludwig-Maximilians-University, Munich, Germany., Mundle SD; Janssen Global Services, Raritan, NJ, USA., Fleming S; Janssen Global Services, Titusville, NJ, USA., Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Publikováno v: World journal of urology [World J Urol] 2023 Dec; Vol. 41 (12), pp. 3535-3542. Date of Electronic Publication: 2023 Nov 15.
Zobrazit plný text záznamu
9
Akademický článek
Real-world treatment patterns, costs, and outcomes in patients with AL amyloidosis: analysis of the Optum EHR and commercial claims databases.
Autor: Dispenzieri A; Mayo Clinic, Rochester, MN, USA., Zonder J; Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA., Hoffman J; Sylvester Comprehensive Cancer Center, Miami, FL, USA., Wong SW; Division of Hematology/Oncology, University of California, San Francisco, CA, USA., Liedtke M; Department of Medicine, Stanford University, Stanford, CA, USA., Abonour R; Indiana Cancer Pavilion, Indianapolis, IN, USA., D'Souza A; Froedtert & Medical College of Wisconsin Cancer Center, Milwaukee, WI, USA., Lee C; Janssen Global Services, Raritan, NJ, USA., Cote S; Janssen Global Services, Raritan, NJ, USA., Potluri R; SmartAnalyst, Inc, New York, NY, USA., Ammann E; Janssen Global Services, Raritan, NJ, USA., Tran N; Janssen Research & Development, LLC, Los Angeles, CA, USA., Lam A; Janssen Global Services, Raritan, NJ, USA., Nair S; Janssen Pharmaceutica NV, Beerse, Belgium.
Publikováno v: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2023 Jun; Vol. 30 (2), pp. 161-168. Date of Electronic Publication: 2022 Oct 25.
Zobrazit plný text záznamu
10
Akademický článek
Teclistamab versus real-world physician's choice of therapy in triple-class exposed relapsed/refractory multiple myeloma.
Autor: Krishnan A; Judy and Bernard Briskin Center for Multiple Myeloma Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA., Nooka AK; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA., Chari A; Division of Hematology/Oncology, Mount Sinai School of Medicine, New York, NY 10029-5674, USA., Garfall AL; Abramson Cancer Center, Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Martin TG; UCSF Helen Diller Family Comprehensive Cancer Center, Division of Hematology and Blood and Marrow Transplantation, Department of Medicine, San Francisco, CA 94143, USA., Nair S; Janssen Pharmaceutica NV, Beerse, B-2340, Belgium., Lin X; Janssen Global Services, Horsham, PA 19044, USA., Qi K; Janssen Research & Development, Titusville, NJ 08560, USA., Londhe A; Janssen Research & Development, Titusville, NJ 08560, USA., Pei L; Janssen Research & Development, Raritan, NJ 08869, USA., Ammann E; Janssen Global Services, Raritan, NJ 08869, USA., Kobos R; Janssen Research & Development, Raritan, NJ 08869, USA., Smit J; Janssen Global Services, Horsham, PA 19044, USA., Parekh T; Janssen Research & Development, Bridgewater, NJ 08869, USA., Marshall A; Janssen Global Services, Raritan, NJ 08869, USA., Slavcev M; Janssen Global Services, Raritan, NJ 08869, USA., Usmani SZ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2023 Jun; Vol. 12 (6), pp. e220186. Date of Electronic Publication: 2023 Apr 28.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje